We are thrilled to announce the resounding success of the AHEA Summit 2024, held in conjunction with JPM2024. This event has marked a significant milestone in our journey towards healthcare innovation and global collaboration.

Networking Session: Cultivating Connections

The summit began with a networking session, providing a platform for industry professionals to connect and exchange ideas in a vibrant environment. The experience was enhanced with a complimentary selection of gourmet cuisine.

Opening Remarks: Visionary Leadership

After the networking session, Lei Wang, the Executive Vice President & International and China President of AstraZeneca, and Yisu Jin, the Founder of SVLC, AHEA, and IntelliPro Group, graced the stage for the opening remarks. Lei Wang, renowned for her strategic leadership in the pharmaceutical industry, and Yisu Jin, celebrated for his entrepreneurial acumen and recognition in the 2023 Forbes 100 Most Influential Chinese list, established an insightful tone for the summit's discussions.

Lei Wang emphasized the summit's goal, stating, "The establishment of AHEA aims to provide a platform for global healthcare leaders to come together and discuss global healthcare trends. This platform is designed to facilitate discussions that can help drive global transactions and create more possibilities to address unmet clinical needs."

Panel Discussions: In-Depth Industry Analysis

Panel 1: Value Creation By Global Partnership

Next, the first panel discussion focused on "Value Creation By Global Partnership," featuring:

• Dr. Alex J. Zhang (Moderator), Founder and CEO of OneTwenty Therapeutics, Inc.
• Dr. Bing Yuan, Founder and CEO of OnCusp Therapeutics.
• Dr. Per Jr. Greisen, Vice President of BioMap.
• Dr. Renee Williams, Founder & Managing Partner of Williams Biotech Consulting.
• Dr. Weiyong Sun, CBO of Hansoh Bio.

The panelists explored case studies of successful collaborations, strategies for overcoming cross-border challenges, and the role of technology in facilitating international alliances. This session underscored the significance of diverse perspectives and expertise in advancing healthcare outcomes on a global scale.

Panel 2: Navigating Investment Opportunities in 2024

Following the first panel, the second panel discussion, "Navigating Investment Opportunities in 2024," included:

• Aaron Gu (Moderator), Partner at Han Kun Law Offices.
• Dr. Bin Li, Founder, CEO, and CIO of Lake Bleu Capital.
• Dr. Jielun Zhu, CFO and CIO of Fapon Group.
• Dr. Lana Dinić, Senior Director of Portfolio Strategy and Program Management at Flagship Pioneering.
• Dr. Vincent Xiang, Founder of 7G BioVentures.

The panelists convened to provide valuable insights into the evolving trends landscape within the healthcare sector.

AHEA’s Mission: Promoting Collaborative Innovation

Our mission at AHEA is clear and forward-thinking: to catalyze and nurture successful partnerships by harnessing disruptive technology and innovative platforms. This strategic approach is designed to significantly influence and reshape the healthcare landscape. Our ambition is to establish ourselves as the go-to advisors for the next generation of industry trailblazers.

In line with our vision, we see AHEA as a pivotal connector and facilitator in the realm of scientific and business collaborations. We are committed to being the bridge that links different sectors, fostering scientific collaboration, and crafting robust business partnerships. This dedication positions us not just as participants but as key drivers in enhancing global healthcare collaboration, thereby contributing profoundly to the advancement of the healthcare industry worldwide.

As we reflect on the success of the AHEA Summit 2024, we look forward with renewed vigor to our continued role in shaping the future of healthcare. Our commitment to innovation, collaboration, and leadership in the healthcare industry remains unwavering.